Share This

Public company info - CANbridge Pharmaceuticals Inc. , 01228.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

CANbridge Pharmaceuticals Inc., 01228.HK - Cash Flow 2021-12 2020-12 2019-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12 2006-12 2005-12
Net Cash Flow from Operating Activities -589,677 -152,612 -126,295 -536,612 -106,245 -61,954 -62,608 21,694 -24,767 -627 190,339 56,698 -13,777
Net Cash Flow from Return on Investments & Servicing of Finance 1,228 -4,027 -494 -13,934 29 1 113 797 -3,936 -39,534 -6,094 -3,228 -19,007
　Interest Received 2,607 964 160 69 29 1 113 797 10,327 802 5,244 1,191 882
　Interest Paid -1,379 -4,991 -654 -14,003 0 0 0 0 -14,263 -40,336 -11,338 -4,419 -2,609
　Dividend Received 0 0 0 0 0 0 0 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0 0 0 0 0 0 -17,280
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 -437 0 -3 -16 -2,053 -1,888 -1,102 -1,414 -1,215
Net Cash Flow from Investing Activities 126,094 -153,483 -42,460 -41,819 -1,828 38 -30,963 -52,052 -41,242 -15,683 -191,295 -27,967 -56,983
　Additions to Fixed Assets -5,087 -2,571 -1,080 -11,755 -1,856 -202 -16,155 -2,139 -18,276 -19,297 -13,267 -24,481 -52,378
　Disposal of Fixed Assets 0 0 16 0 28 0 96 325 1,671 791 2,202 0 0
　Increase in Investments 0 0 -12,000 -698,720 0 240 -23,981 0 0 0 -181,145 0 0
　Decrease in Investments 0 0 12,000 668,656 0 0 9,077 -50,238 -7,498 2,823 915 -323 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0 0 0 0 0 0 0
　Others 131,181 -150,912 -41,396 0 0 0 0 0 -17,139 0 0 -3,163 -4,605
Net Cash Flow before Financing Activities -462,355 -310,122 -169,249 -592,365 -108,481 -61,915 -93,461 -29,577 -71,998 -57,732 -8,152 24,089 -90,982
Net Cash Flow from Financing Activities 855,689 684,254 97,621 695,681 127,034 57,896 -1,041 0 140,564 -24,330 165,430 2,526 50,160
　New Loans 20,761 21,530 26,131 0 0 0 1,000 0 0 0 0 0 67,002
　Loans Repayment -32,083 -18,072 -3,720 -198,000 -737 -1,000 0 0 0 -28,066 -43,333 -50,336 -16,842
　Fixed Income/Debt Instruments 334,899 681,062 76,284 273,000 0 0 0 0 0 0 23,728 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 -8,000 0 0 0 0 -50,000 0 0 0 0
　Equity Financing 532,112 985 0 613,681 127,771 51,696 0 0 190,564 2,832 185,035 52,862 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0 0 0 0 0 0 0
　Others 0 -1,251 -1,074 15,000 0 7,200 -2,041 0 0 904 0 0 0
Increase(Decrease) in Cash & Cash Equivalents 393,334 374,132 -71,628 103,316 18,553 -4,019 -94,502 -29,577 68,566 -82,062 157,278 26,615 -40,822
Cash & Cash Equivalents at Beginning of Year 360,804 13,873 85,240 32,400 2,498 5,494 99,964 122,951 54,582 138,205 101,253 67,144 105,795
Net Cash Flow due to Change in Exchange Rate/Others -8,323 -27,201 261 -6,050 11,349 1,023 251 6,590 -197 -1,561 -120,326 7,494 2,171
Cash & Cash Equivalents at End of Year 745,815 360,804 13,873 129,666 32,400 2,498 5,713 99,964 122,951 54,582 138,205 101,253 67,144
Currency Renminbi Renminbi Renminbi Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar
Unit Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 1 0 0 1 1 1 1 1 1 2 1 1 1

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.